JP2012020953A5 - - Google Patents

Info

Publication number

JP2012020953A5

JP2012020953A5 JP2010159031A JP2010159031A JP2012020953A5 JP 2012020953 A5 JP2012020953 A5 JP 2012020953A5 JP 2010159031 A JP2010159031 A JP 2010159031A JP 2010159031 A JP2010159031 A JP 2010159031A JP 2012020953 A5 JP2012020953 A5 JP 2012020953A5

Authority

JP

Japan

Prior art keywords

fulminant

inflammation

agent according

type

pneumonia

Prior art date

2010-07-13

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 206010061218 Inflammation Diseases 0.000 claims 5
• 230000004054 inflammatory process Effects 0.000 claims 5
• 239000003795 chemical substances by application Substances 0.000 claims 4
• XJSFLOJWULLJQS-NGVXBBESSA-N josamycin Chemical compound CO[C@H]1[C@H](OC(C)=O)CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](N(C)C)[C@H](O[C@@H]2O[C@@H](C)[C@H](OC(=O)CC(C)C)[C@](C)(O)C2)[C@@H](C)O1 XJSFLOJWULLJQS-NGVXBBESSA-N 0.000 claims 4
• 229960004144 josamycin Drugs 0.000 claims 4
• 206010035664 Pneumonia Diseases 0.000 claims 3
• ACTOXUHEUCPTEW-BWHGAVFKSA-N 2-[(4r,5s,6s,7r,9r,10r,11e,13e,16r)-6-[(2s,3r,4r,5s,6r)-5-[(2s,4r,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2s,5s,6r)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-o Chemical compound O([C@H]1/C=C/C=C/C[C@@H](C)OC(=O)C[C@@H](O)[C@@H]([C@H]([C@@H](CC=O)C[C@H]1C)O[C@H]1[C@@H]([C@H]([C@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(O)C2)[C@@H](C)O1)N(C)C)O)OC)[C@@H]1CC[C@H](N(C)C)[C@@H](C)O1 ACTOXUHEUCPTEW-BWHGAVFKSA-N 0.000 claims 2
• 239000004187 Spiramycin Substances 0.000 claims 2
• 239000003814 drug Substances 0.000 claims 2
• XJSFLOJWULLJQS-UHFFFAOYSA-N leucomycin A3 Natural products COC1C(OC(C)=O)CC(=O)OC(C)CC=CC=CC(O)C(C)CC(CC=O)C1OC1C(O)C(N(C)C)C(OC2OC(C)C(OC(=O)CC(C)C)C(C)(O)C2)C(C)O1 XJSFLOJWULLJQS-UHFFFAOYSA-N 0.000 claims 2
• 230000000069 prophylactic effect Effects 0.000 claims 2
• 150000003839 salts Chemical class 0.000 claims 2
• 229960001294 spiramycin Drugs 0.000 claims 2
• 229930191512 spiramycin Natural products 0.000 claims 2
• 235000019372 spiramycin Nutrition 0.000 claims 2
• 208000011580 syndromic disease Diseases 0.000 claims 2
• 229940124597 therapeutic agent Drugs 0.000 claims 2
• 241000712461 unidentified influenza virus Species 0.000 claims 2
• 208000027932 Collagen disease Diseases 0.000 claims 1
• 208000001940 Massive Hepatic Necrosis Diseases 0.000 claims 1
• 206010058858 Meningococcal bacteraemia Diseases 0.000 claims 1
• 208000009525 Myocarditis Diseases 0.000 claims 1
• 206010033645 Pancreatitis Diseases 0.000 claims 1
• 208000004756 Respiratory Insufficiency Diseases 0.000 claims 1
• 206010040047 Sepsis Diseases 0.000 claims 1
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 1
• 239000004480 active ingredient Substances 0.000 claims 1
• 206010009887 colitis Diseases 0.000 claims 1
• 201000010099 disease Diseases 0.000 claims 1
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
• 208000009190 disseminated intravascular coagulation Diseases 0.000 claims 1
• 201000004792 malaria Diseases 0.000 claims 1
• 238000004519 manufacturing process Methods 0.000 claims 1
• 201000004193 respiratory failure Diseases 0.000 claims 1
• 230000009385 viral infection Effects 0.000 claims 1